Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Nektar Therapeutics

http://www.nektar.com

Latest From Nektar Therapeutics

Bristol’s Opdivo Stumbles On Its Way To First-Line Bladder Cancer Indication

The CheckMate-901 trial failed on one of its primary endpoints, but the company will continue the trial to explore additional primary endpoints.

Cancer ImmunoOncology

US Delisting Risk Hits I-Mab Hard, Bilateral Agreement Needed?

It started with the risk of delisting from US stock markets over auditing requirements, but there are other underlying risks for Chinese bioventures that ultimately only some form of bilateral governmental agreement may need to address, but this may be increasingly hard to reach.

Financing Compliance

BMS’s Revlimid Loss Of Exclusivity Is Not As Bad As Expected, But Not For Long

The company credited generics’ late market entry, but that benefit is not expected to last; the firm lowered guidance for annual sales of the oncologic.

Sales & Earnings Strategy

BMS’s Revlimid Loss Of Exclusivity Is Not As Bad As Expected, But Not For Long

The company credited generics’ late market entry, but that benefit is not expected to last; the firm lowered guidance for annual sales of the oncologic. The firm stressed growth opportunities ahead for Opdivo, Opdualag and Camzyos.

Companies Sales & Earnings
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
      • Macromolecule
  • Biotechnology
    • Drug Discovery Tools
    • Large Molecule
  • Other Names / Subsidiaries
    • Aerogen, Inc.
    • Inhale Therapeutic Systems, Inc.
    • Inheris Biopharma, Inc.
    • Nektar Therapeutics (India) Private Limited
UsernamePublicRestriction

Register